Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

4D Molecular Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Emeryville, CA, United States

  1. PrincipalsDavid KirnChief Executive OfficerKristian HumerChief Financial OfficerScott BizilyChief Legal Officerand 4 more
  2. Company4D Molecular Therapeutics, Inc.Emeryville, CA, United States
  3. Phone line+1 (510) 505-2680General business
Request a quote

4D Molecular Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker FDMT) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 7

Chief executive

David KirnChief Executive Officer

Chair & board

Charles TheuerDirector (Board)
Glenn SblendorioDirector (Board)

Finance

Kristian HumerChief Financial Officer
Ashoo GuptaVP, Finance and Controller

Legal

Scott BizilyChief Legal Officer
Everyone else on file (1)
Christopher Paul SimmsOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. David Kirn — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Scott Bizily — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Kristian Humer — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Ashoo Gupta — VP, Finance and Controller

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers